CAPTRUST FINANCIAL ADVISORS - IMMUCELL CORP ownership

IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 28 filers reported holding IMMUCELL CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of IMMUCELL CORP
ValueSharesWeighting
Q2 2022$2,000
-83.3%
200
-83.3%
0.00%
Q1 2022$12,000
+500.0%
1,200
+500.0%
0.00%
Q4 2021$2,0000.0%2000.0%0.00%
Q3 2021$2,0000.0%2000.0%0.00%
Q2 2021$2,0000.0%2000.0%0.00%
Q1 2021$2,000
+100.0%
2000.0%0.00%
Q4 2020$1,0000.0%2000.0%0.00%
Q3 2020$1,0000.0%2000.0%0.00%
Q2 2020$1,0002000.00%
Other shareholders
IMMUCELL CORP shareholders Q3 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 168,323$1,153,0000.54%
NORTHPOINTE CAPITAL LLC 255,309$1,749,0000.22%
PERRITT CAPITAL MANAGEMENT INC 82,579$566,0000.14%
HEARTLAND ADVISORS INC 203,100$1,391,0000.07%
Minerva Advisors LLC 14,559$100,0000.07%
Essex Financial Services, Inc. 23,776$163,0000.04%
SHUFRO ROSE & CO LLC 42,191$289,0000.03%
USA MUTUALS ADVISORS, INC. 471$3,0000.00%
Renaissance Technologies 56,707$388,0000.00%
Tower Research Capital LLC (TRC) 700$5,0000.00%
View complete list of IMMUCELL CORP shareholders